Angelini, Eleonora
Albert, Karolin
Duncker, David
Article History
Accepted: 22 September 2025
First Online: 16 October 2025
Declarations
:
: D. Duncker received moderate speaker fees, travel grants, and/or a fellowship grant from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, and ZOLL. E. Angelini and K. Albert declare that they have no competing interests.
: This article does not contain any studies with human participants or animals performed by any of the authors.